Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

Presentation THT Abstracts 2025

Temporal and Demographic Trends of Cardiogenic Shock Mortality in the United States: A Two Decade Analysis

Presenter: Sherif Eltawansy

February 11, 2025

Presentation THT Abstracts 2025

Tafamidis Impact on Incidence of Pacemaker and ICD Placement in ATTR-CM Patients

Presenter: Justin Pawloski

February 11, 2025

Presentation THT Abstracts 2025

ECG-Based Deep Learning Algorithm for Risk Stratification of Left Ventricular Systolic Dysfunction: A Retrospective Single-Center Study

Presenter: Neil Keshvani

February 11, 2025

Presentation THT Abstracts 2025

The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes

Presenter: Navneet Sandhu

February 11, 2025

Presentation THT Abstracts 2025

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

Presenter: Kevin John

February 11, 2025

Presentation THT Abstracts 2025

Acute Hemodynamic Effects of VA-ECMO on Arterial Afterload in a Preclinical Model of Normal Left Ventricular Function After Exposure to Vasodilators

Presenter: Kay Everett

February 11, 2025

Presentation THT Abstracts 2025

An Admittance Pulmonary Artery Catheter for Right Ventricular Pressure-Volume Measurements

Presenter: Luis Diaz Sanmartin

February 11, 2025

Presentation THT Abstracts 2025

Trend and Impact of Right Heart Catheterization on Outcomes in Cardiogenic Shock

Presenter: Qianlan Xi

February 11, 2025

Presentation THT Abstracts 2025

Validation of Left Ventricular Ejection Time Measurement With CardioTag Wearable Patch Hardware

Presenter: Venu Ganti

February 11, 2025

Presentation THT Abstracts 2025

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Presenter: Qianlan Xi

February 11, 2025

Presentation THT Abstracts 2025

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Presenter: Thitiphan Srikulmontri

February 11, 2025

Presentation THT Abstracts 2025

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Presenter: Neha Panigrahy

February 11, 2025

Presentation THT Abstracts 2025

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Presenter: Kivanc Ozonat

February 11, 2025

Presentation THT Abstracts 2025

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Presenter: Miguel Woodham

February 11, 2025

Presentation THT Abstracts 2025

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Presenter: Qianlan Xi

February 11, 2025

Presentation THT Abstracts 2025

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Presenter: Javed Butler

February 11, 2025

Presentation THT Abstracts 2025

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Presenter: Dmitry Yaranov

February 11, 2025

Presentation THT Abstracts 2025

Flow Restoration Leads to LV Mass Regression After DurAVR® Biomimetic THV Implant: MRI Study

February 11, 2025

Presentation THT Abstracts 2025

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

February 11, 2025

Presentation THT Abstracts 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Advertisement

Temporal and Demographic Trends of Cardiogenic Shock Mortality in the United States: A Two Decade Analysis

Tafamidis Impact on Incidence of Pacemaker and ICD Placement in ATTR-CM Patients

ECG-Based Deep Learning Algorithm for Risk Stratification of Left Ventricular Systolic Dysfunction: A Retrospective Single-Center Study

The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

Acute Hemodynamic Effects of VA-ECMO on Arterial Afterload in a Preclinical Model of Normal Left Ventricular Function After Exposure to Vasodilators

An Admittance Pulmonary Artery Catheter for Right Ventricular Pressure-Volume Measurements

Trend and Impact of Right Heart Catheterization on Outcomes in Cardiogenic Shock

Validation of Left Ventricular Ejection Time Measurement With CardioTag Wearable Patch Hardware

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Flow Restoration Leads to LV Mass Regression After DurAVR® Biomimetic THV Implant: MRI Study

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content